Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

被引：58

作者：

Fendler, Annika ^{[1
]}

Shepherd, Scott T. C. ^{[1
,14
,15
]}

Au, Lewis ^{[1
,14
,15
]}

Wu, Mary ^{[2
]}

Harvey, Ruth ^{[3
]}

Schmitt, Andreas M. ^{[14
,15
]}

Tippu, Zayd ^{[1
,14
,15
]}

Shum, Benjamin ^{[1
,14
,15
]}

Farag, Sheima ^{[14
,15
]}

Rogiers, Aljosja ^{[14
,15
]}

Carlyle, Eleanor ^{[14
,15
]}

Edmonds, Kim ^{[14
,15
]}

Del Rosario, Lyra ^{[14
,15
]}

Lingard, Karla ^{[14
,15
]}

Mangwende, Mary ^{[14
,15
]}

Holt, Lucy ^{[14
,15
]}

Ahmod, Hamid ^{[14
,15
]}

Korteweg, Justine ^{[14
,15
]}

Foley, Tara ^{[14
,15
]}

Barber, Taja ^{[1
]}

Emslie-Henry, Andrea ^{[1
]}

Caulfield-Lynch, Niamh ^{[1
]}

Byrne, Fiona ^{[1
]}

Deng, Daqi ^{[1
]}

Kjaer, Svend ^{[4
]}

Song, Ok-Ryul ^{[2
]}

Queval, Christophe ^{[2
]}

Kavanagh, Caitlin ^{[2
]}

Wall, Emma C. ^{[2
,23
]}

Carr, Edward J. ^{[5
]}

Caidan, Simon ^{[6
]}

Gavrielides, Mike ^{[7
]}

MacRae, James I. ^{[8
]}

Kelly, Gavin ^{[9
]}

Peat, Kema ^{[14
,15
]}

Kelly, Denise ^{[14
,15
]}

Murra, Aida ^{[14
,15
]}

Kelly, Kayleigh ^{[14
,15
]}

O'Flaherty, Molly ^{[14
,15
]}

Shea, Robyn L. ^{[16
,24
]}

Gardner, Gail ^{[16
]}

Murray, Darren ^{[16
]}

Yousaf, Nadia ^{[17
,18
]}

Jhanji, Shaman ^{[19
]}

Tatham, Kate ^{[19
]}

Cunningham, David ^{[20
]}

Van As, Nicholas ^{[21
]}

Young, Kate ^{[14
,15
]}

Furness, Andrew J. S. ^{[14
,15
]}

Pickering, Lisa ^{[14
,15
]}

机构：

[1] Francis Crick Inst, Canc Dynam Lab, London NW1 1AT, England

[2] Francis Crick Inst, High Throughput Screening Lab, London NW1 1AT, England

[3] Francis Crick Inst, Worldwide Influenza Ctr, London NW1 1AT, England

[4] Francis Crick Inst, Struct Biol Sci Technol Platform, London NW1 1AT, England

[5] Francis Crick Inst, Cell Biol Infect Lab, London NW1 1AT, England

[6] Francis Crick Inst, Safety Hlth & Sustainabil, London NW1 1AT, England

[7] Francis Crick Inst, Sci Comp Sci Technol Platform, London NW1 1AT, England

[8] Francis Crick Inst, Metabol Sci Technol Platform, London NW1 1AT, England

[9] Francis Crick Inst, Dept Bioinformat & Biostat, London NW1 1AT, England

[10] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London NW1 1AT, England

[11] Francis Crick Inst, Neurodegenerat Biol Lab, London NW1 1AT, England

[12] Francis Crick Inst, Struct Biol Dis Processes Lab, London NW1 1AT, England

[13] Francis Crick Inst, RNA Virus Replicat Lab, London NW1 1AT, England

[14] Royal Marsden NHS Fdn Trust, Skin Unit, London, England

[15] Royal Marsden NHS Fdn Trust, Renal Unit, London, England

[16] Royal Marsden NHS Fdn Trust, Dept Pathol, London, England

[17] Royal Marsden NHS Fdn Trust, Lung Unit, London, England

[18] Royal Marsden NHS Fdn Trust, Acute Oncol Serv, London, England

[19] Royal Marsden NHS Fdn Trust, Anaesthet Perioperat Med & Pain Dept, London, England

[20] Royal Marsden NHS Fdn Trust, Gastrointestinal Unit, London, England

[21] Royal Marsden NHS Fdn Trust, Clincal Oncol Unit, London, England

[22] Royal Marsden NHS Fdn Trust, Haematooncol Unit, London, England

[23] Univ Coll London Hosp NHS Fdn Trust, Biomed Res Ctr, London, England

[24] Inst Canc Res, Translat Canc Biochem Lab, London, England

[25] Inst Canc Res, Melanoma & Kidney Canc Team, London, England

[26] UCL, Div Med, London, England

[27] UCL, Inst Canc, London, England

[28] UCL Queen Sq Inst Neurol, London, England

来源：

LANCET | 2022年 / 399卷 / 10328期

关键词：

D O I：

10.1016/S0140-6736(22)00147-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：905 / 907

页数：3

共 50 条

[31] Third dose of COVID-19 vaccine: is there any place for it for pregnant women?
Sookaromdee, Pathum
Wiwanitkit, Viroj
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2023, 24 (04) : 289 - 290
[32] The Effectiveness of the Third Dose of COVID-19 Vaccine: When Should It Be Performed?
Biganzoli, Giacomo
Mendola, Marco
Perrone, Pier Mario
Antonangeli, Laura Maria
Longo, Anna Beatrice Elena
Carrer, Paolo
Colosio, Claudio
Consonni, Dario
Marano, Giuseppe
Boracchi, Patrizia
Biganzoli, Elia
Castaldi, Silvana
VACCINES, 2024, 12 (03)
[33] Expected usefulness of the third dose COVID-19 vaccine for cancerous patient
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (03) : 846 - 846
[34] Covid-19: Experts advise cautious optimism for neutralising antibodies after early results
Mahase, Elisabeth
BMJ-BRITISH MEDICAL JOURNAL, 2020, 371 : m3937
[35] Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents
Leung, Daniel
Cohen, Carolyn A.
Mu, Xiaofeng
Rosa Duque, Jaime S.
Cheng, Samuel M. S.
Wang, Xiwei
Wang, Manni
Zhang, Wenyue
Zhang, Yanmei
Tam, Issan Y. S.
Lam, Jennifer H. Y.
Chan, Sau Man
Chaothai, Sara
Kwan, Kelvin K. H.
Chan, Karl C. K.
Li, John K. C.
Luk, Leo L. H.
Tsang, Leo C. H.
Chu, Nym Coco
Wong, Wilfred H. S.
Mori, Masashi
Leung, Wing Hang
Valkenburg, Sophie
Peiris, Malik
Tu, Wenwei
Lau, Yu Lung
FRONTIERS IN IMMUNOLOGY, 2023, 14
[36] COVID-19 pandemic after Omicron
Lai, Christopher K. C.
Lam, Wilson
Tsang, K. Y.
Cheng, Frankie W. T.
Wong, Martin C. S.
HONG KONG MEDICAL JOURNAL, 2022, 28 (03) : 196 - 198
[37] Effectiveness of fourth dose of COVID-19 vaccine against the Omicron variant compared with no vaccination
Zeng, Jessie
Szanyi, Joshua
Blakely, Tony
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2023, 52 (01) : 321 - +
[38] Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients (vol 398, pg 1038, 2021)
Carr, E. J.
Wu, M.
Harvey, R.
LANCET, 2021, 398 (10305): : 1042 - 1042
[39] COVID-19 Vaccine response in cancer patients
Segelov, Eva
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 107 - 108
[40] Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine
Charmetant, Xavier
Espi, Maxime
Barba, Thomas
Ovize, Anne
Morelon, Emmanuel
Mathieu, Cyrille
Thaunat, Olivier
AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (05) : 1442 - 1450

← 1 2 3 4 5 →